Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health, (NIOSH), 4048 [2012-1687]
Download as PDF
<![CDATA[
4048
Federal Register / Vol. 77, No. 17 / Thursday, January 26, 2012 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Safety and Occupational Health Study
Section (SOHSS), National Institute for
Occupational Safety and Health,
(NIOSH)
mstockstill on DSK4VPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Times and Dates
8 a.m.–5 p.m., February 22, 2012
(Closed),
8 a.m.–5 p.m., February 23, 2012
(Closed).
PLACE: Embassy Suites, 1900 Diagonal
Road, Alexandria, Virginia 22314,
Telephone: (703) 684–5900, Fax: (703)
684–0653.
STATUS: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
PURPOSE: The Safety and Occupational
Health Study Section will review,
discuss, and evaluate grant
application(s) received in response to
the Institute’s standard grants review
and funding cycles pertaining to
research issues in occupational safety
and health, and allied areas.
It is the intent of NIOSH to support
broad-based research endeavors in
keeping with the Institute’s program
goals. This will lead to improved
understanding and appreciation for the
magnitude of the aggregate health
burden associated with occupational
injuries and illnesses, as well as to
support more focused research projects,
which will lead to improvements in the
delivery of occupational safety and
health services, and the prevention of
work-related injury and illness. It is
anticipated that funded research will
promote these program goals.
MATTERS TO BE DISCUSSED: The meeting
will convene to address matters related
to the conduct of Study Section
business and for the study section to
consider safety and occupational healthrelated grant applications.
These portions of the meeting will be
closed to the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
VerDate Mar<15>2010
17:14 Jan 25, 2012
Jkt 226001
Management Analysis and Services
Office, Centers for Disease Control and
Prevention, pursuant to Section 10(d)
Public Law 92–463.
Agenda items are subject to change as
priorities dictate.
CONTACT PERSON FOR MORE INFORMATION:
Price Connor, Ph.D., NIOSH Health
Scientist, 2400 Executive Parkway,
Mailstop E–20, Atlanta, Georgia 30345,
Telephone: (404) 498–2511, Fax: (404)
498–2571.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: January 18, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–1687 Filed 1–25–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Evaluation of Dengue
Epidemiology, Outcomes, and
Prevention in Sentinel Surveillance and
Research Sites in Puerto Rico, Funding
Opportunity Announcement (FOA),
CK12–001, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 1 p.m.–5 p.m., April 18,
2012 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Evaluation of Dengue
Epidemiology, Outcomes and Prevention in
Sentinel Surveillance and Research Sites in
Puerto Rico, FOA CK12–001, initial review.’’
Contact Person for More Information: Greg
Anderson, MPH, MS, Scientific Review
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Officer, CDC, 1600 Clifton Road NE.,
Mailstop E60, Atlanta, Georgia 30333,
Telephone: (404) 718–8833.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: January 18, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–1675 Filed 1–25–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Arthritis and
Musculoskeletal and Skin Diseases Initial
Review Group, Arthritis and Musculoskeletal
and Skin Diseases Special Grants Review
Committee.
Date: February 23–24, 2012.
Time: 7:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Helen Lin, Ph.D.,
Scientific Review Officer, NIH/NIAMS/RB,
6701 Democracy Blvd., Suite 800, Bethesda,
MD 20817, (301) 594–4952, linh1@mail.nih.
gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
E:\FR\FM\26JAN1.SGM
26JAN1
]]>Agencies
[Federal Register Volume 77, Number 17 (Thursday, January 26, 2012)]
[Notices]
[Page 4048]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-1687]
[[Page 4048]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Safety and Occupational Health Study Section (SOHSS), National
Institute for Occupational Safety and Health, (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Times and Dates
8 a.m.-5 p.m., February 22, 2012 (Closed),
8 a.m.-5 p.m., February 23, 2012 (Closed).
Place: Embassy Suites, 1900 Diagonal Road, Alexandria, Virginia 22314,
Telephone: (703) 684-5900, Fax: (703) 684-0653.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C.,
and the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Purpose: The Safety and Occupational Health Study Section will review,
discuss, and evaluate grant application(s) received in response to the
Institute's standard grants review and funding cycles pertaining to
research issues in occupational safety and health, and allied areas.
It is the intent of NIOSH to support broad-based research endeavors
in keeping with the Institute's program goals. This will lead to
improved understanding and appreciation for the magnitude of the
aggregate health burden associated with occupational injuries and
illnesses, as well as to support more focused research projects, which
will lead to improvements in the delivery of occupational safety and
health services, and the prevention of work-related injury and illness.
It is anticipated that funded research will promote these program
goals.
Matters To Be Discussed: The meeting will convene to address matters
related to the conduct of Study Section business and for the study
section to consider safety and occupational health-related grant
applications.
These portions of the meeting will be closed to the public in
accordance with provisions set forth in Section 552b(c)(4) and (6),
Title 5 U.S.C., and the Determination of the Director, Management
Analysis and Services Office, Centers for Disease Control and
Prevention, pursuant to Section 10(d) Public Law 92-463.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Price Connor, Ph.D., NIOSH Health
Scientist, 2400 Executive Parkway, Mailstop E-20, Atlanta, Georgia
30345, Telephone: (404) 498-2511, Fax: (404) 498-2571.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention and the Agency for
Toxic Substances and Disease Registry.
Dated: January 18, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-1687 Filed 1-25-12; 8:45 am]
BILLING CODE 4163-18-P
